Test PET/CT imaging using a cancer-targeting tracer
Part of Cancer clinical trials.
This early-phase trial uses a special PET/CT scan tracer called 68Ga-ICAM-1pep to help doctors find and stage cancers. You may be able to join if you have (or are suspected to have) certain cancers and can safely complete the scan steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- Your general function is good (ECOG 0 or 1, meaning you’re able to do most daily activities)
- Your doctor is recommending a PET/CT scan to diagnose or stage your cancer (lung, esophagus, cervical, or other cancers)
- You are not pregnant and not breastfeeding
- Your liver and kidneys are working well enough for the study
- Your white blood cell count is not too low (not less than 3 x 10^9/L)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET/CT scan (called 68Ga-NYM096) to see if it can help find different types of cancer. The scan may help doctors get clearer pictures of where cancer is in your body.
This trial evaluates a new radioactive tracer that targets a protein called EpCAM found on many solid tumors. It aims to improve PET/CT scans for diagnosing and staging cancer. Participants will receive the tracer before their scheduled biopsy or surgery.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This early-phase study tests special PET/CT scans using a radioactive tracer to see cancer areas that have specific targets. It may help doctors better visualize tumors and plan next steps, using scans that you may already be familiar with (FDG) plus targeted tracers.
This trial uses a special PET scan to take pictures of certain solid tumors. The scan uses a new dye that may help doctors see the tumors more clearly. You may be eligible if you have one of the listed cancers and are between 18 and 75 years old with good daily function.
This trial studies how well a specific PET/CT scan using a radioactive tracer can detect or evaluate cancers. It may help doctors see where cancer is in the body more clearly.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.